aminolevulinic acid has been researched along with Barrett Epithelium in 61 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The percentage regression of Barrett esophagus, as well as the recurrence rate of HGD/EC, was calculated." | 5.33 | Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. ( Aalders, M; Bergman, J; Fockens, P; Kara, M; Krishnadath, K; Peters, F; Rosmolen, W; Ten Kate, F; van Lanschot, J, 2005) |
| "All patients had residual Barrett esophagus after PDT; the median regression percentage was 50 % (IQR 25 - 70 %)." | 5.33 | Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. ( Aalders, M; Bergman, J; Fockens, P; Kara, M; Krishnadath, K; Peters, F; Rosmolen, W; Ten Kate, F; van Lanschot, J, 2005) |
| "Surveillance of patients with Barrett's esophagus or ulcerative colitis for dysplasia is confined to biopsy specimens taken randomly during endoscopy because dysplasia remains undetectable by visual inspection." | 5.30 | Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. ( Bäumler, W; Holstege, A; Knüchel, R; Messmann, H; Schölmerich, J, 1999) |
| "Eleven patients with high-grade mucosal dysplasia in a columnar-lined oesophagus and 2 patients with a squamous carcinoma (uT1) underwent photodynamic therapy (PDT) and argon-plasma coagulation (APC)." | 3.70 | [Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus--an alternative to surgery?]. ( Beger, HG; Orth, K; Rück, A; Russ, D; Stanescu, A, 1999) |
| " The aim of this study was to establish the optimum dosage regime for ALA-PDT for Barrett's esophagus." | 2.71 | Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Brown, SB; Kelty, CJ; Reed, MW, 2004) |
| " There was no significant difference in response between dosing 4 or 6 h prior to PDT." | 2.71 | Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Brown, SB; Kelty, CJ; Reed, MW, 2004) |
| "Twenty-five patients with Barrett's esophagus were randomized to receive 30 (low-dose) or 60 (high-dose) mg/kg oral ALA at 4 or 6 h or 30 mg/kg in two fractions 4 and 6 h before PDT." | 2.71 | Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Brown, SB; Kelty, CJ; Reed, MW, 2004) |
| "Barrett's esophagus is the major risk factor for esophageal adenocarcinoma, the incidence of which is increasing rapidly in the Western world." | 2.71 | Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Brown, SB; Kelty, CJ; Reed, MW, 2004) |
| " This study demonstrates that ALA-induced PDT provides safe and effective ablation therapy for Barrett's esophagus and is particularly useful against dysplasia." | 2.69 | Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Davis, MF; Reed, MW; Stephenson, TJ; Stoddard, CJ, 2000) |
| "Forty patients with dysplastic Barrett's esophagus were given aminolevulinic acid (ALA) 30 mg/kg orally followed 4 h later by laser endoscopy." | 2.69 | Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus. ( Ackroyd, R; Brown, NJ; Davis, MF; Reed, MW; Stephenson, TJ; Stoddard, CJ, 2000) |
| "Surveillance of Barrett's esophagus is routinely undertaken to detect early malignant transformation." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "Barrett's esophagus is a precursor of adenocarcinoma of the esophagus." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "Barrett's esophagus is the major risk factor for the development of esophageal adenocarcinoma, which is increasing in incidence faster than any other cancer in the Western world." | 2.41 | Photodynamic therapy for Barrett's esophagus: a review. ( Ackroyd, R; Kelty, CJ; Marcus, SL, 2002) |
| "Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to detect malignant transformation." | 2.41 | Photodynamic therapy for Barrett's esophagus: a review. ( Ackroyd, R; Kelty, CJ; Marcus, SL, 2002) |
| "Barrett's esophagus has been identified as the premalignant precursor of esophageal adenocarcinoma." | 2.41 | Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. ( Barr, H, 2000) |
| "The percentage regression of Barrett esophagus, as well as the recurrence rate of HGD/EC, was calculated." | 1.33 | Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. ( Aalders, M; Bergman, J; Fockens, P; Kara, M; Krishnadath, K; Peters, F; Rosmolen, W; Ten Kate, F; van Lanschot, J, 2005) |
| "All patients had residual Barrett esophagus after PDT; the median regression percentage was 50 % (IQR 25 - 70 %)." | 1.33 | Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. ( Aalders, M; Bergman, J; Fockens, P; Kara, M; Krishnadath, K; Peters, F; Rosmolen, W; Ten Kate, F; van Lanschot, J, 2005) |
| "Barrett's esophagus is strongly associated with adenocarcinoma." | 1.32 | Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid. ( Dorta, G; Felley, C; Fontolliet, C; Gabrecht, T; Grosjean, P; Jornod, P; Lange, N; Monnier, P; Stepinac, T; van den Bergh, H; vanMelle, G; Wagnières, G, 2003) |
| "14 patients with histologically proven Barrett's esophagus, seven of whom had evidence of low-grade dysplasia, underwent endoscopic treatment with topical delta-ALA." | 1.31 | Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. ( Dietel, M; Ebert, B; Fleige, B; Liebetruth, J; Lochs, H; Ortner, M-; Zumbusch, K, 2002) |
| "Barrett's esophagus is a complication of gastroesophageal reflux disease (GERD) characterized by specialized columnar epithelium that contains goblet cells and replaces the squamous epithelium of the distal esophagus." | 1.31 | [Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid]. ( Endlicher, E; Fürst, A; Knüchel, R; Messmann, H; Schölmerich, J, 2001) |
| "Eight patients with Barrett's esophagus and/or early cancer were treated." | 1.31 | [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study]. ( Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Rosenbaum, A; Zöpf, T, 2001) |
| "Surveillance of patients with Barrett's esophagus or ulcerative colitis for dysplasia is confined to biopsy specimens taken randomly during endoscopy because dysplasia remains undetectable by visual inspection." | 1.30 | Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. ( Bäumler, W; Holstege, A; Knüchel, R; Messmann, H; Schölmerich, J, 1999) |
| "PDT of Barrett's esophagus with severe dysplasia, or of mucosal carcinomas and superficial squamous-cell cancer of the esophagus, requires light application devices allowing homogeneous illumination of the tissue surface in spite of esophageal motility and respiratory movement." | 1.30 | A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. ( Ell, C; Gossner, L; May, A; Sroka, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (26.23) | 18.2507 |
| 2000's | 37 (60.66) | 29.6817 |
| 2010's | 7 (11.48) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Grosenick, D | 1 |
| Bremer, C | 1 |
| Kohoutova, D | 1 |
| Haidry, R | 2 |
| Banks, M | 1 |
| Butt, MA | 1 |
| Dunn, J | 2 |
| Thorpe, S | 2 |
| Lovat, L | 2 |
| Yeh, SC | 2 |
| Ling, CS | 1 |
| Andrews, DW | 2 |
| Patterson, MS | 2 |
| Diamond, KR | 1 |
| Hayward, JE | 1 |
| Armstrong, D | 2 |
| Fang, Q | 2 |
| Sahli, S | 1 |
| Provias, J | 1 |
| Holz, JA | 1 |
| Boerwinkel, DF | 1 |
| Meijer, SL | 1 |
| Visser, M | 1 |
| van Leeuwen, TG | 1 |
| Bergman, JJ | 1 |
| Aalders, MC | 2 |
| Mackenzie, GD | 3 |
| Dunn, JM | 2 |
| Selvasekar, CR | 1 |
| Mosse, CA | 3 |
| Thorpe, SM | 2 |
| Novelli, MR | 3 |
| Bown, SG | 3 |
| Lovat, LB | 3 |
| Gross, SA | 1 |
| Wolfsen, HC | 2 |
| Davila, ML | 1 |
| Banks, MR | 1 |
| Green, S | 1 |
| Rodriguez-Justo, M | 1 |
| Winstanley, A | 1 |
| Ortner, M- | 1 |
| Zumbusch, K | 2 |
| Liebetruth, J | 1 |
| Ebert, B | 2 |
| Fleige, B | 2 |
| Dietel, M | 2 |
| Lochs, H | 3 |
| Hinnen, P | 4 |
| de Rooij, FW | 5 |
| Hop, WC | 1 |
| Edixhoven, A | 4 |
| van Dekken, H | 3 |
| Wilson, JH | 4 |
| Siersema, PD | 8 |
| Kelty, CJ | 5 |
| Marcus, SL | 2 |
| Ackroyd, R | 9 |
| Brand, S | 1 |
| Wang, TD | 1 |
| Schomacker, KT | 1 |
| Poneros, JM | 1 |
| Lauwers, GY | 1 |
| Compton, CC | 1 |
| Pedrosa, MC | 1 |
| Nishioka, NS | 1 |
| van Veen, RL | 2 |
| Pasma, KL | 1 |
| Haringsma, J | 2 |
| van de Vrie, W | 2 |
| Gabeler, EE | 1 |
| Robinson, DJ | 1 |
| Sterenborg, HJ | 2 |
| Ortner, MA | 1 |
| Hein, E | 1 |
| Nolte, D | 1 |
| Sukowski, U | 1 |
| Weber-Eibel, J | 1 |
| Stolte, M | 3 |
| Oberhuber, G | 1 |
| Porschen, R | 1 |
| Klump, B | 1 |
| Hörtnagl, H | 1 |
| Rinneberg, H | 1 |
| Brown, NJ | 6 |
| Stephenson, TJ | 4 |
| Stoddard, CJ | 4 |
| Reed, MW | 6 |
| Stepinac, T | 1 |
| Felley, C | 1 |
| Jornod, P | 1 |
| Lange, N | 2 |
| Gabrecht, T | 1 |
| Fontolliet, C | 1 |
| Grosjean, P | 1 |
| vanMelle, G | 1 |
| van den Bergh, H | 1 |
| Monnier, P | 1 |
| Wagnières, G | 1 |
| Dorta, G | 1 |
| Prosst, RL | 1 |
| Gahlen, J | 1 |
| Brown, SB | 1 |
| Van Laethem, JL | 2 |
| Devière, J | 1 |
| Hage, M | 1 |
| Steyerberg, EW | 1 |
| Grool, TE | 1 |
| Kuipers, EJ | 1 |
| Claydon, PE | 1 |
| Sylantiev, C | 1 |
| Schoenfeld, N | 1 |
| Mamet, R | 1 |
| Groozman, GB | 1 |
| Drory, VE | 1 |
| Peters, F | 1 |
| Kara, M | 1 |
| Rosmolen, W | 1 |
| Aalders, M | 1 |
| Ten Kate, F | 1 |
| Krishnadath, K | 1 |
| van Lanschot, J | 1 |
| Fockens, P | 1 |
| Bergman, J | 1 |
| Pech, O | 2 |
| Gossner, L | 4 |
| May, A | 4 |
| Rabenstein, T | 1 |
| Vieth, M | 1 |
| Berres, M | 1 |
| Ell, C | 4 |
| Abbas, G | 1 |
| Pennathur, A | 1 |
| Keeley, SB | 1 |
| Landreneau, RJ | 1 |
| Luketich, JD | 1 |
| Globe, J | 1 |
| Smythe, A | 1 |
| Jamieson, NF | 1 |
| Clark, BR | 1 |
| Collaud, S | 1 |
| Warloe, T | 1 |
| Jordan, O | 1 |
| Gurny, R | 1 |
| Kelley, DJ | 1 |
| Shah, JP | 1 |
| Barr, H | 2 |
| Shepherd, NA | 1 |
| Dix, A | 1 |
| Roberts, DJ | 1 |
| Tan, WC | 1 |
| Krasner, N | 1 |
| Heller, SJ | 1 |
| Van Dam, J | 1 |
| Vonarx, V | 1 |
| Eleouet, S | 1 |
| Carre, J | 1 |
| Ioss, P | 1 |
| Gouyette, A | 1 |
| Leray, AM | 1 |
| Merle, C | 1 |
| Lajat, Y | 2 |
| Patrice, T | 2 |
| Sroka, R | 2 |
| Rick, K | 1 |
| Hahn, EG | 1 |
| Ortner, M | 1 |
| Messmann, H | 5 |
| Knüchel, R | 3 |
| Endlicher, E | 3 |
| Hauser, T | 2 |
| Szeimies, RM | 2 |
| Kullmann, F | 1 |
| Bäumler, W | 2 |
| Schölmerich, J | 4 |
| van Velthuysen, ML | 1 |
| van Hillegersberg, R | 4 |
| Tilanus, HW | 2 |
| Holstege, A | 1 |
| van den Boogert, J | 2 |
| Houtsmuller, AB | 1 |
| de Bruin, RW | 2 |
| Wang, KK | 2 |
| Fennerty, MB | 1 |
| Orth, K | 1 |
| Stanescu, A | 1 |
| Rück, A | 1 |
| Russ, D | 1 |
| Beger, HG | 1 |
| Keller, R | 1 |
| Fischbach, W | 1 |
| Brown, N | 1 |
| Vernon, D | 1 |
| Roberts, D | 1 |
| Stephenson, T | 1 |
| Marcus, S | 1 |
| Stoddard, C | 1 |
| Reed, M | 1 |
| Terlouw, EM | 1 |
| Davis, MF | 2 |
| Johnson, AG | 1 |
| Knuechel, R | 1 |
| Fürst, A | 1 |
| Zöpf, T | 1 |
| Rosenbaum, A | 1 |
| Apel, D | 1 |
| Jakobs, R | 1 |
| Arnold, JC | 1 |
| Riemann, JF | 1 |
| van Staveren, HJ | 1 |
| Eisendrath, P | 1 |
| Bourre, L | 1 |
| Thibaut, S | 1 |
| Briffaud, A | 1 |
| Nagy, CD | 1 |
12 reviews available for aminolevulinic acid and Barrett Epithelium
| Article | Year |
|---|---|
Fluorescence Imaging of Breast Tumors and Gastrointestinal Cancer.
Topics: Aminolevulinic Acid; Barrett Esophagus; Breast Neoplasms; Female; Fluorescence; Gastrointestinal Neo | 2020 |
The role of photodynamic therapy in the esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2010 |
Photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2011 |
Photodynamic therapy for Barrett's esophagus: a review.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Barrett Esophagus; Dihematoporphyrin Ether; Hematoporphy | 2002 |
Photodynamic therapy for esophageal diseases: a clinical update.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Endosonography; Eso | 2003 |
5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Clinical Trials as Topic; Esophageal Neoplas | 2004 |
Laser ablation therapies for Barrett's esophagus.
Topics: Aminolevulinic Acid; Argon; Barrett Esophagus; Dihematoporphyrin Ether; Humans; Laser Therapy; Photo | 2005 |
Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Topics: Administration, Oral; Aminolevulinic Acid; Animals; Barrett Esophagus; Controlled Clinical Trials as | 2008 |
Current status of photodynamic therapy of Barrett's esophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Epithelium; Esophageal Neoplasms; H | 1999 |
[Fluorescence endoscopy in gastroenterology].
Topics: Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colonic Neoplasms; Endoscopy, Gastroint | 2000 |
Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Humans; Injections, Intravenous; Intestinal M | 2000 |
Photodynamic therapy of Barrett's esophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Fiber Optic Technology; Hematoporphyrin Deriv | 2000 |
12 trials available for aminolevulinic acid and Barrett Epithelium
| Article | Year |
|---|---|
Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Catheter Ablation; Dihematoporp | 2018 |
Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagus; Humans; Kaplan-Meier Estimate; Lasers; Optical Ph | 2009 |
A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Disease Progr | 2013 |
Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Endoscopy; Female | 2002 |
In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagus; Humans; Light; Photochemotherapy; Photosensitizin | 2002 |
Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Cohort | 2004 |
5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.
Topics: Aged; Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Female; Follow-Up Studies; Humans; Lase | 2004 |
Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Female; Follo | 2004 |
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus.
Topics: Acrylic Resins; Adhesiveness; Administration, Oral; Administration, Topical; Adult; Aminolevulinic A | 2007 |
5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Topics: Aminolevulinic Acid; Barrett Esophagus; Humans; Photochemotherapy; Photosensitizing Agents; Protopor | 1999 |
Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Follow-Up Studies; Humans; Photochemotherapy; Photosensitizi | 2000 |
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Topics: Adult; Aged; Aminolevulinic Acid; Anti-Ulcer Agents; Barrett Esophagus; Double-Blind Method; Drug Th | 2000 |
37 other studies available for aminolevulinic acid and Barrett Epithelium
| Article | Year |
|---|---|
5-aminolevulinic acid for quantitative seek-and-treat of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Aminolevulinic Acid; Barrett Esophagus; Cell Line, Tumor; Cell Survival; Humans; Intracellular Space | 2015 |
5-Aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Adenocarcinoma; Algorithms; Aminolevulinic Acid; Barrett Esophagus; Biomarkers; Esophageal Neoplasms | 2015 |
Fluorescence characteristics of human Barrett tissue specimens grafted on chick chorioallantoic membrane.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Biopsy; Chickens; Chorioallantoic Membrane; Humans; | 2016 |
Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pho | 2002 |
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esopha | 2002 |
Time gated fluorescence spectroscopy in Barrett's oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Biomarkers, | 2003 |
Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Topics: Aminolevulinic Acid; Barrett Esophagus; Cell Line, Transformed; Cells, Cultured; Ferrochelatase; Hum | 2002 |
Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Ulcer Agents; Barrett Esophagus; Esophagos | 2003 |
Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Carcinoma in Situ; Esopha | 2003 |
Endoscopic therapy of Barrett's: what more do we need to know?
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophagoscopy; Humans; Photochemotherapy; Photosensitizing A | 2004 |
Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Diagnosis, Different | 2005 |
Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Topics: Aged; Aminolevulinic Acid; Barrett Esophagus; Chemotherapy, Adjuvant; Cohort Studies; Esophagoscopy; | 2005 |
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Disease-Free Survival; Esophageal Neop | 2005 |
The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Female; Gastric Acid; Humans; Hydro | 2006 |
How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Dose-Response Relationship, Radiati | 2008 |
Management of Barrett's oesophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Humans; Photochemotherapy; Proton Pump Inhibitors | 1996 |
Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Humans; Male; Middle Aged; Photoche | 1996 |
Eradication of high-grade dysplasia using 5-ALA and acid suppression: a (photo)dynamic duo.
Topics: Aminolevulinic Acid; Barrett Esophagus; Gastric Acid; Humans | 1997 |
Potential efficacy of a delta 5-aminolevulinic acid bioadhesive gel formulation for the photodynamic treatment of lesions of the gastrointestinal tract in mice.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Biocompatible Materials; Disease Models, Animal; Fi | 1997 |
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Female | 1998 |
[Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Fe | 1998 |
[Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].
Topics: Adenoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colorectal Neopla | 1998 |
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Topics: Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Female; Ferroc | 1998 |
Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Topics: Adenomatous Polyps; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Colitis, Ulcerative | 1999 |
Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.
Topics: Administration, Oral; Aminolevulinic Acid; Animals; Barrett Esophagus; Disease Models, Animal; Esoph | 1999 |
Perspectives on endoscopic eradication of Barrett's esophagus: who are appropriate candidates and what is the best method?
Topics: Aminolevulinic Acid; Barrett Esophagus; Biopsy; Electrocoagulation; Endoscopy; Endoscopy, Gastrointe | 1999 |
[Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus--an alternative to surgery?].
Topics: Aged; Aminolevulinic Acid; Argon; Barrett Esophagus; Carcinoma; Esophageal Neoplasms; Female; Humans | 1999 |
A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Carcinoma, Squamous Cell; Card | 1999 |
[Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis or colorectal adenomas].
Topics: Adenomatous Polyps; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Colitis, Ulcerative; Colorectal | 1999 |
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett E | 2000 |
Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.
Topics: Administration, Oral; Administration, Topical; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Esoph | 2001 |
[Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid].
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasm | 2001 |
[Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study].
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Cell Transformation, Neoplastic; Esoph | 2001 |
Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Esophagus; Male; Photochemotherapy; Protoporphyrins | 2001 |
Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitization.
Topics: Administration, Oral; Administration, Topical; Aminolevulinic Acid; Barrett Esophagus; Cell Transfor | 2002 |
Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.
Topics: Aminolevulinic Acid; Animals; Barrett Esophagus; Drug Stability; Gastric Mucosa; Gels; Male; Mice; M | 2002 |
Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Barrett Esophagus; Esophageal Neoplasms; Humans; Mice; | 2002 |